Viewing Study NCT03939533


Ignite Creation Date: 2025-12-25 @ 2:51 AM
Ignite Modification Date: 2026-03-03 @ 2:42 PM
Study NCT ID: NCT03939533
Status: COMPLETED
Last Update Posted: 2023-11-07
First Post: 2019-05-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases
Sponsor: Octapharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Immune Deficiency Disorder View
Keywords: